Xwell, INC DEF 14A proxy statements

XWELL, Inc. will hold its 2025 Annual Meeting to vote on proposals including a reverse stock split, board classification, and significant equity issuances to maintain Nasdaq listing and secure financing.

XWELL, Inc. files a supplement to its proxy statement to correct language regarding a proposed reverse stock split aimed at increasing its share price to meet Nasdaq's minimum bid requirement.

XWELL, Inc. issued a supplement to its proxy statement, correcting the voting requirement for its Board Classification Proposal ahead of the September 16, 2025 Annual Meeting.

XWELL, Inc. announces its 2025 Annual Meeting of Stockholders, seeking approval for a reverse stock split to address Nasdaq's minimum bid price requirement and other key corporate governance proposals.

XWELL Inc. is holding a special meeting to vote on proposals including authorizing stock issuance, classifying the Board of Directors, amending the equity incentive plan, ratifying the accounting firm, and adjourning the meeting if necessary.

XWELL, Inc. is convening a special meeting of stockholders to vote on proposals including authorizing share issuance related to a recent securities purchase agreement, classifying the board of directors, amending the equity incentive plan, ratifying the auditor, and adjourning the meeting if necessary.

XWELL Inc. announces the withdrawal of Scott R. Milford as a director nominee due to his resignation as CEO, effective September 4, 2024, and as a director, effective September 21, 2024, ahead of the upcoming Special Meeting of Stockholders on September 20, 2024.

XWELL, Inc. is holding its annual meeting of stockholders on September 20, 2024, to vote on director elections, auditor ratification, executive compensation, and a tax benefits preservation plan.

XWELL, Inc. has implemented a Tax Benefits Preservation Plan to safeguard approximately $67.3 million in net operating losses from potential limitations due to ownership changes.

XWELL Inc. reports that CPC Pain & Wellness SPV, LLC has withdrawn its threatened proxy fight and related lawsuit concerning the company's 2024 annual meeting of stockholders.

XWELL, Inc. announces that CPC Pain & Wellness' director candidate nomination notice is invalid due to deficiencies and calls for CPC to update its Schedule 13D filing with accurate information.

XWELL, Inc. has filed a proxy statement with the SEC regarding its 2024 annual meeting of stockholders, urging stockholders to read the document and accompanying materials carefully.